BioStem Technologies, Inc. (BSEM)
4.858
+0.03
(+0.58%)
USD |
OTCM |
Apr 14, 15:54
BioStem Technologies Cash from Investing (TTM) : -2.102M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Plus Therapeutics, Inc. | -0.854M |
| Iovance Biotherapeutics, Inc. | 47.50M |
| Protokinetix, Inc. | -0.0414M |
| GB Sciences, Inc. | 0.00 |
| Travere Therapeutics, Inc. | 27.89M |